Impact of Ban on FDCs on Therapy Areas & Companies

The Major Market Impacted is Respiratory with 16.9% of the Market coming under this effect followed by Pain & Analgesics Market at 8.2% and Anti-Diabetic at 7.68%

Brands severely impacted are Corex, Phensedyl and Panderm Plus.

Source: AIOCD Pharmasofttech AWACS